« Return to News | Study Conduct

Katzen Eye Group partners with RxTrials

Monday, November 14, 2011 12:06 PM

Katzen Eye Group, a private provider of eye care services in Maryland, has partnered with RxTrials, to provide clinical research study support in ophthalmology and optometry.

With 18 clinical providers, Katzen Eye Group serves an active and varied patient population of 180,000, for indications that include cataract surgery, retina, glaucoma, refractive surgery, and dry eye, as well as routine eye and contact lens care.

"We have the ideal population to help advance eye care," explains Richard C. Edlow, DO, Katzen Eye Group's CEO. "Our electronic medical records system is optimized to enable us to identify and contact appropriate potential study subjects. We are very pleased to partner with RxTrials, who in our opinion, has the expertise and experience we need to do research right."

Katzen Eye Group is equipped to conduct clinical research studies, with
comprehensive testing and diagnostic capabilities and essential equipment in all three locations. Past research experience includes studies in macular edema, age-related macular degeneration, retinal detachment, and implants, among others. All 11 principal investigators are trained in clinical study practice, human subject protections, and federal compliance standards.

"As we look to grow our network of partner sites strategically, we seek sites that can adhere to our high standards for quality, professionalism and ethics," said Adam Chasse, RxTrials' vice president of corporate development. "Katzen Eye Group is a high quality addition to our network and enables us to enhance our therapeutic capabilities in ophthalmology and optometry."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.